Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 6.79x is 43% above its estimated 5-year average of 4.73x, near the high end of its estimated 5-year range (3.45x–7.32x).
As of 2026-09-16T14:55:31.518Z. 9.61% above its estimated 12-month average of 6.19x.
Calculation as of: 2026-09-16T14:55:31.518Z.
Quote observation: 2026-09-16T14:55:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dbbc172ebf6967f14997ab0770433539d073c5c180c2253a0628224f590af452
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
6.79x
EV/SALES RATIO AVG TTM
6.19x
EV/SALES RATIO AVG 3Y
5.14x
EV/SALES RATIO AVG 5Y
4.73x
EV/SALES RATIO AVG 10Y
4.35x
EV/SALES RATIO AVG 15Y
4.80x
EV/SALES RATIO AVG 20Y
5.90x
CURRENT VS TTM AVG
+9.61%
CURRENT VS 3Y AVG
+31.99%
CURRENT VS 5Y AVG
+43.43%
CURRENT VS 10Y AVG
+56.16%
CURRENT VS 15Y AVG
+41.43%
CURRENT VS 20Y AVG
+15.02%
SECTOR MEDIAN · HEALTHCARE
3.69x
median of 87 covered companies
CURRENT VS SECTOR MEDIAN
+84.01%
vs the sector median at left
Gilead Sciences, Inc.
Market Cap
$183.65B
EV/Sales Ratio
6.79x
TTM Avg
6.19x
3Y Avg
5.14x
5Y Avg
4.73x
Market Cap
$178.09B
EV/Sales Ratio
4.41x
TTM Avg
4.67x
3Y Avg
4.98x
5Y Avg
4.91x
Market Cap
$146.14B
EV/Sales Ratio
6.71x
TTM Avg
6.55x
3Y Avg
7.17x
5Y Avg
6.92x
Market Cap
$135.34B
EV/Sales Ratio
12.01x
TTM Avg
16.55x
3Y Avg
19.15x
5Y Avg
18.12x
Market Cap
$130.61B
EV/Sales Ratio
3.35x
TTM Avg
3.11x
3Y Avg
3.10x
5Y Avg
3.43x
Market Cap
$130.75B
EV/Sales Ratio
10.03x
TTM Avg
9.52x
3Y Avg
10.11x
5Y Avg
9.22x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | $183.65B | 6.79x | 6.19x | 5.14x | 4.73x |
| Novo Nordisk A/S (NVO)vs › | $186.26B | 3.93x | 4.72x | 9.89x | 10.68x |
| Abbott Laboratories (ABT)vs › | $178.09B | 4.41x | 4.67x | 4.98x | 4.91x |
| Amgen Inc. (AMGN)vs › | $202.45B | 6.45x | 6.40x | 6.60x | 6.40x |
| Pfizer Inc. (PFE)vs › | $156.56B | 3.43x | 3.33x | 3.49x | 3.53x |
| Danaher Corporation (DHR)vs › | $146.14B | 6.71x | 6.55x | 7.17x | 6.92x |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.34B | 12.01x | 16.55x | 19.15x | 18.12x |
| Bristol-Myers Squibb Company (BMY)vs › | $130.61B | 3.35x | 3.11x | 3.10x | 3.43x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.75B | 10.03x | 9.52x | 10.11x | 9.22x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $239.29B | 5.99x | 5.31x | 5.37x | 5.58x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-09-11 | 6.62x |
| 2026-09-10 | 6.67x |
| 2026-09-09 | 6.70x |
| 2026-09-08 | 6.74x |
| 2026-09-04 | 6.92x |
| 2026-09-03 | 6.93x |
| 2026-09-02 | 6.86x |
| 2026-09-01 | 6.88x |
| 2026-08-31 | 6.73x |
| 2026-08-28 | 6.70x |
| 2026-08-27 | 6.83x |
| 2026-08-26 | 6.80x |
| 2026-08-25 | 6.83x |
| 2026-08-24 | 6.75x |
| 2026-08-21 | 6.72x |
| 2026-08-20 | 6.61x |
| 2026-08-19 | 6.78x |
| 2026-08-18 | 6.61x |
| 2026-08-17 | 6.43x |
| 2026-08-14 | 6.40x |
| 2026-08-13 | 6.40x |
| 2026-08-12 | 6.30x |
| 2026-08-11 | 6.30x |
| 2026-08-10 | 6.19x |
| 2026-08-07 | 6.19x |
| 2026-08-06 | 6.01x |
| 2026-08-05 | 6.05x |
| 2026-08-04 | 6.19x |
| 2026-08-03 | 6.02x |
| 2026-07-31 | 5.98x |
| 2026-07-30 | 6.03x |
| 2026-07-29 | 6.09x |
| 2026-07-28 | 6.15x |
| 2026-07-27 | 5.99x |
| 2026-07-24 | 5.94x |
| 2026-07-23 | 6.01x |
| 2026-07-22 | 5.99x |
| 2026-07-21 | 5.98x |
| 2026-07-20 | 6.11x |
| 2026-07-17 | 6.15x |
| 2026-07-16 | 6.24x |
| 2026-07-15 | 6.04x |
| 2026-07-14 | 5.97x |
| 2026-07-13 | 6.03x |
| 2026-07-10 | 5.96x |
| 2026-07-09 | 6.18x |
| 2026-07-08 | 6.22x |
| 2026-07-07 | 6.24x |
| 2026-07-06 | 5.96x |
| 2026-07-02 | 6.03x |
| 2026-07-01 | 5.80x |
| 2026-06-30 | 5.82x |
| 2026-06-29 | 5.82x |
| 2026-06-26 | 5.88x |
| 2026-06-25 | 5.71x |
| 2026-06-24 | 5.77x |
| 2026-06-23 | 5.76x |
| 2026-06-22 | 5.76x |
| 2026-06-18 | 5.71x |
| 2026-06-17 | 5.78x |
| 2026-06-16 | 5.85x |
| 2026-06-15 | 5.73x |
| 2026-06-12 | 5.79x |
| 2026-06-11 | 5.80x |
| 2026-06-10 | 5.61x |
| 2026-06-09 | 5.78x |
| 2026-06-08 | 5.89x |
| 2026-06-05 | 5.94x |
| 2026-06-04 | 5.94x |
| 2026-06-03 | 5.93x |
| 2026-06-02 | 5.87x |
| 2026-06-01 | 6.02x |
| 2026-05-29 | 6.16x |
| 2026-05-28 | 6.23x |
| 2026-05-27 | 6.13x |
| 2026-05-26 | 6.13x |
| 2026-05-22 | 6.16x |
| 2026-05-21 | 5.99x |
| 2026-05-20 | 6.00x |
| 2026-05-19 | 5.99x |
| 2026-05-18 | 5.96x |
| 2026-05-15 | 5.95x |
| 2026-05-14 | 6.06x |
| 2026-05-13 | 6.10x |
| 2026-05-12 | 6.18x |
| 2026-05-11 | 6.12x |
| 2026-05-08 | 6.03x |
| 2026-05-07 | 6.30x |
| 2026-05-06 | 6.39x |
| 2026-05-05 | 6.27x |
| 2026-05-04 | 6.24x |
| 2026-05-01 | 6.19x |
| 2026-04-30 | 6.16x |
| 2026-04-29 | 6.07x |
| 2026-04-28 | 6.09x |
| 2026-04-27 | 6.03x |
| 2026-04-24 | 6.14x |
| 2026-04-23 | 6.28x |
| 2026-04-22 | 6.25x |
| 2026-04-21 | 6.26x |
| 2026-04-20 | 6.37x |
| 2026-04-17 | 6.45x |
| 2026-04-16 | 6.49x |
| 2026-04-15 | 6.54x |
| 2026-04-14 | 6.57x |
| 2026-04-13 | 6.51x |
| 2026-04-10 | 6.51x |
| 2026-04-09 | 6.64x |
| 2026-04-08 | 6.61x |
| 2026-04-07 | 6.50x |
| 2026-04-06 | 6.55x |
| 2026-04-02 | 6.54x |
| 2026-04-01 | 6.56x |
| 2026-03-31 | 6.52x |
| 2026-03-30 | 6.39x |
| 2026-03-27 | 6.30x |
| 2026-03-26 | 6.42x |
| 2026-03-25 | 6.47x |
| 2026-03-24 | 6.47x |
| 2026-03-23 | 6.44x |
| 2026-03-20 | 6.43x |
| 2026-03-19 | 6.60x |
| 2026-03-18 | 6.60x |
| 2026-03-17 | 6.74x |
| 2026-03-16 | 6.77x |
| 2026-03-13 | 6.76x |
| 2026-03-12 | 6.77x |
| 2026-03-11 | 6.80x |
| 2026-03-10 | 6.91x |
| 2026-03-09 | 6.83x |
| 2026-03-06 | 6.72x |
| 2026-03-05 | 6.77x |
| 2026-03-04 | 6.90x |
| 2026-03-03 | 6.88x |
| 2026-03-02 | 6.98x |
| 2026-02-27 | 6.93x |
| 2026-02-26 | 6.71x |
| 2026-02-25 | 6.85x |
| 2026-02-24 | 6.97x |
| 2026-02-23 | 7.07x |
| 2026-02-20 | 7.13x |
| 2026-02-19 | 7.12x |
| 2026-02-18 | 7.19x |
| 2026-02-17 | 7.30x |
| 2026-02-13 | 7.29x |
| 2026-02-12 | 7.15x |
| 2026-02-11 | 7.32x |
| 2026-02-10 | 6.95x |
| 2026-02-09 | 7.14x |
| 2026-02-06 | 7.18x |
| 2026-02-05 | 7.05x |
| 2026-02-04 | 6.91x |
| 2026-02-03 | 6.78x |
| 2026-02-02 | 6.77x |
| 2026-01-30 | 6.73x |
| 2026-01-29 | 6.62x |
| 2026-01-28 | 6.63x |
| 2026-01-27 | 6.68x |
| 2026-01-26 | 6.55x |
| 2026-01-23 | 6.47x |
| 2026-01-22 | 6.26x |
| 2026-01-21 | 6.17x |
| 2026-01-20 | 5.96x |
| 2026-01-16 | 5.99x |
| 2026-01-15 | 5.83x |
| 2026-01-14 | 5.95x |
| 2026-01-13 | 5.85x |
| 2026-01-12 | 5.89x |
| 2026-01-09 | 5.83x |
| 2026-01-08 | 5.81x |
| 2026-01-07 | 5.97x |
| 2026-01-06 | 5.84x |
| 2026-01-05 | 5.71x |
| 2026-01-02 | 5.85x |
| 2025-12-31 | 5.90x |
| 2025-12-30 | 5.92x |
| 2025-12-29 | 5.99x |
| 2025-12-26 | 5.98x |
| 2025-12-24 | 6.02x |
| 2025-12-23 | 6.00x |
| 2025-12-22 | 5.96x |
| 2025-12-19 | 5.96x |
| 2025-12-18 | 5.84x |
| 2025-12-17 | 5.84x |
| 2025-12-16 | 5.73x |
| 2025-12-15 | 5.77x |
| 2025-12-12 | 5.80x |
| 2025-12-11 | 5.92x |
| 2025-12-10 | 5.84x |
| 2025-12-09 | 5.75x |
| 2025-12-08 | 5.83x |
| 2025-12-05 | 5.83x |
| 2025-12-04 | 5.89x |
| 2025-12-03 | 5.99x |
| 2025-12-02 | 5.95x |
| 2025-12-01 | 5.97x |
| 2025-11-28 | 6.03x |
| 2025-11-26 | 6.10x |
| 2025-11-25 | 6.09x |
| 2025-11-24 | 6.01x |
| 2025-11-21 | 6.07x |
| 2025-11-20 | 5.99x |
| 2025-11-19 | 6.13x |
| 2025-11-18 | 6.09x |
| 2025-11-17 | 5.96x |
| 2025-11-14 | 6.00x |
| 2025-11-13 | 6.00x |
| 2025-11-12 | 5.93x |
| 2025-11-11 | 5.89x |
| 2025-11-10 | 5.70x |
| 2025-11-07 | 5.85x |
| 2025-11-06 | 6.05x |
| 2025-11-05 | 6.02x |
| 2025-11-04 | 6.03x |
| 2025-11-03 | 5.99x |
| 2025-10-31 | 5.89x |
| 2025-10-30 | 5.84x |
| 2025-10-29 | 5.84x |
| 2025-10-28 | 5.81x |
| 2025-10-27 | 5.92x |
| 2025-10-24 | 5.94x |
| 2025-10-23 | 5.94x |
| 2025-10-22 | 5.97x |
| 2025-10-21 | 6.08x |
| 2025-10-20 | 6.04x |
| 2025-10-17 | 6.03x |
| 2025-10-16 | 5.81x |
| 2025-10-15 | 5.83x |
| 2025-10-14 | 5.84x |
| 2025-10-13 | 5.83x |
| 2025-10-10 | 5.78x |
| 2025-10-09 | 5.76x |
| 2025-10-08 | 5.83x |
| 2025-10-07 | 5.76x |
| 2025-10-06 | 5.62x |
| 2025-10-03 | 5.59x |
| 2025-10-02 | 5.49x |
| 2025-10-01 | 5.52x |
| 2025-09-30 | 5.51x |
| 2025-09-29 | 5.58x |
| 2025-09-26 | 5.56x |
| 2025-09-25 | 5.51x |
| 2025-09-24 | 5.63x |
| 2025-09-23 | 5.66x |
| 2025-09-22 | 5.58x |
| 2025-09-19 | 5.65x |
| 2025-09-18 | 5.63x |
| 2025-09-17 | 5.57x |
| 2025-09-16 | 5.51x |
| 2025-09-15 | 5.58x |
| 2025-09-12 | 5.67x |
| 2025-09-11 | 5.81x |
| 2025-09-10 | 5.70x |
| 2025-09-09 | 5.72x |
| 2025-09-08 | 5.72x |
| 2025-09-05 | 5.69x |
| 2025-09-04 | 5.59x |
| 2025-09-03 | 5.60x |
| 2025-09-02 | 5.59x |
| 2025-08-29 | 5.60x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
